Hochman David P

Hochman David P, See Remarks, Director, has filed 5 insider trading reports covering 1 company. Total disclosed trading volume is $197.6K. The predominance of buying activity ($90.3K in purchases vs. $0 in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves Orchestra BioMed Holdings, Inc. (OBIO). All transactions sourced from SEC Form 4 filings.